Lonza L7 hiPSC Reprogramming and hPSC Culture System

Friday, 27 June, 2014 | Supplied by: Capsugel Australia Pty Ltd

Lonza introduces its L7 hiPSC Reprogramming and hPSC Culture System for basic stem-cell research, disease modelling, drug development and regenerative medicine. The offering includes tools to simplify and streamline the stem-cell culturing and reprogramming workflow. The culture system supports the generation of reproducible, clinically relevant data as a solid basis for more efficient drug development and accelerated progress in regenerative medicine.

The stem-cell reprogramming and culture system includes seven key components that are aligned and function as a robust workflow: primary cells, including disease phentoypes; Nucleofector technology; hPSC reprogramming kits; hPSC medium; hPSC matrix; hPC passaging solution; hPSC cryosolution.

The culture system is claimed to be the only complete solution for the generation of induced pluripotent stem-cells (iPSCs), the maintenance of human embryonic stem-cells (hESCs) and iPSCs under defined, xeno-free conditions. It allows for every other day feeding and supports long-term culture and maintenance of hPSCs. The system thus provides a seamless transition from the lab bench to clinical development applications.

Online: www.capsugel.com
Phone: 1300 657508
Related Products

Enzo Life Sciences SUPERKILLERTRAIL protein (soluble) (human), (recombinant)

Enzo Life Sciences' SUPERKILLERTRAIL (soluble) (human), (recombinant) is an enhanced ligand...

Diaclone ELISpot Kits

Diaclone's ELISpot Kits are highly specific immunoassays for the analysis of the production...

Bio-Rad Laboratories Bio-Plex Pro Human SARS-CoV-2 Variant Neutralization Antibody Assays

The assays allow scientists to measure neutralising antibodies quickly and efficiently against...

  • All content Copyright © 2022 Westwick-Farrow Pty Ltd